Enhancing Molecular Property Prediction with Knowledge from Large Language Models
By: Peng Zhou , Lai Hou Tim , Zhixiang Cheng and more
Potential Business Impact:
Finds new medicines faster using smart computer knowledge.
Predicting molecular properties is a critical component of drug discovery. Recent advances in deep learning, particularly Graph Neural Networks (GNNs), have enabled end-to-end learning from molecular structures, reducing reliance on manual feature engineering. However, while GNNs and self-supervised learning approaches have advanced molecular property prediction (MPP), the integration of human prior knowledge remains indispensable, as evidenced by recent methods that leverage large language models (LLMs) for knowledge extraction. Despite their strengths, LLMs are constrained by knowledge gaps and hallucinations, particularly for less-studied molecular properties. In this work, we propose a novel framework that, for the first time, integrates knowledge extracted from LLMs with structural features derived from pre-trained molecular models to enhance MPP. Our approach prompts LLMs to generate both domain-relevant knowledge and executable code for molecular vectorization, producing knowledge-based features that are subsequently fused with structural representations. We employ three state-of-the-art LLMs, GPT-4o, GPT-4.1, and DeepSeek-R1, for knowledge extraction. Extensive experiments demonstrate that our integrated method outperforms existing approaches, confirming that the combination of LLM-derived knowledge and structural information provides a robust and effective solution for MPP.
Similar Papers
$\text{M}^{2}$LLM: Multi-view Molecular Representation Learning with Large Language Models
Machine Learning (CS)
Helps find new medicines by understanding molecules better.
M-GLC: Motif-Driven Global-Local Context Graphs for Few-shot Molecular Property Prediction
Machine Learning (CS)
Finds new medicines with less data.
Combining GCN Structural Learning with LLM Chemical Knowledge for Enhanced Virtual Screening
Machine Learning (CS)
Finds new medicines faster by understanding molecule shapes.